Author guidelines
Overview
Before submitting
Manuscript formatting
Article types
Supplementary data
Editorial policies
Overview
Before submitting
- Approval – Ensure all authors have seen and approved the final version of the article prior to submission and are aware it is being submitted to Reproduction.
- Open access – The appropriate open-access option must be selected on submission. Authors are responsible for ensuring any funder mandates are followed. For further details, please see the open-access policy.
- Charges – Reproduction does not charge for publication, but some charges may apply for Supplemental Data. Full details are available on our publication charges page.
- Ethical compliance – All articles are required to meet the requirements outlined in our ethical policy. Ensure you have included all relevant ethical approval statements.
- Author list – All authors must be listed on the title page and entered on the ScholarOne Manuscripts submission in the correct order. Ensure all author email addresses provided are valid. Author information entered into ScholarOne Manuscripts will be used to generate PubMed listings for published papers.
- Cover letter – This letter should introduce your paper and outline why your work is important and suitable for publication at this time.
- English language – Non-native English speakers are encouraged to have their manuscript professionally edited before submission. See Bioscientifica’s recommended English language editing services. Manuscripts may be written in either UK or US English.
User account details
ORCID iD
All submitting authors are required to link their ScholarOne account with their ORCID iD. The system will prompt the author to do this when creating the submission.
The journal also requests that all authors identified as ‘corresponding authors’ create and link an ORCID iD with their account on ScholarOne prior to article acceptance. We also encourage contributing authors to associate an ORCID iD with their ScholarOne account. Author ORCID iDs will be displayed on the published article.
Important: please ensure your ORCID ID is complete, with full publication history. If a blank ORCID ID is received, it is at the editors discretion to request an up to date publication history.
Author email addresses
The journal requires an institutional email address is associated with the account of both the submitting author and corresponding author; please edit the associated ScholarOne accounts to include this before pressing 'submit'. Alternatively please provide an explanation as to why this is not available to the Editorial Office by contacting reproduction@bioscientifica.com
This policy has been adopted in order to verify the authenticity of article submissions and protect the integrity of Reproduction.
Manuscript formatting
- Please be aware that the combined size of your files should not exceed 40 MB
- For article text: txt, doc, docx, rtf. We are unable to accept PDF files for article text for revised manuscripts, but can do so for first submissions.
- For figures: eps, tiff, jpg
Article types
Research papers
1. Title Page
- Title. The title should be short and informative, giving the main point of the paper (with a maximum of 85 characters). It should include species and avoid vague phrases such as 'The effect of', 'alters' etc. The main subjects of the paper (hormone, gene, tissue) should be included to increase discoverability of your work.
- All authors' names and full addresses.
- Corresponding author’s postal and email address.
- A short title (maximum 46 characters, including spaces).
- A minimum of four keywords describing the manuscript.
- Word count of the full article, excluding references and figure legends.
2. Abstract
3. In brief
In brief: Obese chickens display an ovarian disorder similar to PCOS in women, which is often treated with metformin. This study shows that metformin may also improve follicle function in hens.
In brief: The establishment and maintenance of pregnancy in mammals require the continuous function of the corpus luteum (CL) and its ability to secrete progesterone. This paper reveals the role of a novel protein in CL survival in ruminants.
4. Introduction
5. Materials and methods
- Include the source of chemicals, reagents and hormones and give the manufacturer’s name in parentheses.
- Give the generic name, dose and route of administration for drugs.
- Specify the composition of buffers, solutions and culture media.
- Use SI symbols, give concentrations in mol/L and define the term % as w/v or v/v for all solutions. For international units use IU (U should be used for enzyme activity).
- Specify the type of equipment (microscopes/objective lenses, cameras, detectors) used to obtain images.
- RT-PCR methods should broadly follow the MIQE guidelines, see http://miqe.gene-quantification.info/ and Bustin et al 2009 Clin Chem 55:611-622.
- Submissions using qPCR data and a single reference (normalization/housekeeping) gene must provide substantial evidence that the selected gene remains invariable under experimental conditions. Authors are directed to the MIQE guidelines for further detail when preparing their data.
- Methods for extracellular vesicle purification and characterisation should follow the guidelines set out in the MISEV guidelines, Théry et al 2018, doi.org/10.1080/20013078.2018.1535750.
- The EQUATOR network provides a database of reporting guidelines, aiming to improve the reliability of published health research literature by promoting transparent and accurate reporting. Authors may find this a useful resource.
- Specify any image acquisition software used, and give a description of specialized techniques requiring large amounts of processing, such as confocal, deconvolution, 3D reconstructions, or surface and volume rendering.
6. Results
7. Discussion
8. Declaration of interest, Funding, Contributions and Acknowledgements
Declaration of interest
Actual or perceived conflicts of interest for all authors must be declared in full.
Please either (a) declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported; or (b) fully declare any financial or other potential conflict of interest.
- Employment and consultancies
- Grants, fees and honoraria
- Ownership of stock or shares
- Royalties
- Patents (pending and actual)
- Board membership
Please detail all of the sources of funding relevant to the research reported in the following format:
This work was supported by the Medical Research Council (grant numbers xxxx, yyyy); the Wellcome Trust (grant number xxxx); and Tommy’s Baby charity (grant number xxxx).
This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.
Please include a statement concisely specifying the contribution of each co-author. Use author initials to indicate contributions, for example:
CP conceived the study and wrote the paper. GF performed experiments and analysed data.
Please be as brief as possible.
9. References
Any unpublished work (personal communications, manuscripts in preparation and manuscripts submitted but not yet accepted for publication) must be referred to in the text and not listed in the references.
(A Stone, J Brown & MR Smith, unpublished observations)
(J Brown, personal communication)
Cite references in the text using the authors’ names and publication year. Use et al. for articles with more than two authors. Where there are several citations, list them in chronological order.
List references in alphabetical order. Give articles by the same author in the order:
- Single author
- Two authors alphabetically according to the name of the second author
- Three or more authors chronologically, with a, b and c etc for articles published in the same year, in the order in which they are cited in the text
See RH, Calvo D, Shi Y, Kawa H, Luke MP & Yuan Z 2001 Stimulation of p300-mediated transcription by the kinase MEKK1. Journal of Biological Chemistry 276 16310–16317.
Harvey SS 1975 Hypnotics and sedatives. The barbiturates. In The Pharmacological Basis of Therapeutics, edn 5, pp 102–123. Eds LS Goodman & A Gilman. New York: Macmillan Publishing Co.
Please use Harvard style (Author, Year). Do not use an Endnote style which abbreviates the reference list in your submitted article.
10. Statistical analysis
- Describe the numbers of experimental units used and the way in which they have been allocated to treatments
- Justify the omission of any observations from the analysis
- Describe methods of analysis precisely and state any necessary assumptions, as these may affect the conclusions that can be drawn from the experiment
11. Tables
- Number tables in the order they are cited in the text
- Include a title – a single sentence at the head of the table that includes the name of the organism studied
- Use footnotes to provide any additional explanatory material, cross-referenced to the column entries
- Give a short heading for each column
- Do not use internal horizontal or vertical lines, colour or shading
- Explain all abbreviations used in the table in the footnotes
12. Figures
- Number figures in the order they are cited in the text
- Include legends to all figures, giving the figure number, keys to any symbols used, the name of the organism studied, the names of any statistical tests used and the probability levels used for comparisons
- Label figure sections as A, B etc in the top left-hand corner
- Use Arial or a similar sans-serif font for text labels
- Do not enclose figures in boxes
- Indicate magnification by a scale bar in the bottom right-hand corner of the image and give the measurement in the legend
- Use the preferred symbols of closed and open circles, squares and triangles. Ensure that symbols are large enough to be read clearly when the figure is reduced for publication
- Use Courier or a similar non-proportional font for amino acid, DNA, RNA and PCR primer sequences and highlight sections of homology between sequences with grey shading
- Submissions containing images of electrophoretic blots, gels, and microscopy must provide original, uncropped and unadjusted images as additional files for review (please see the Supplementary data heading for further detail).
Reproduction is committed to publishing high quality figures.
- Line images/graphs: EPS, TIFF, high-resolution PDF, AI (Adobe Illustrator). Resolution at final published size: 1200 dpi.
- Half-tone (greyscale) images: TIFF, high-resolution PDF, JPEG. Resolution at final published size: 600 dpi.
- Colour images: TIFF, high-resolution PDF, JPEG. EPS or AI files can be used for graphical data and illustrations that don’t include photographs. Resolution at final published size: 300 dpi. Colour format: CMYK (not RGB).
13. Videos
Reviews
Point of view
Length – 1500 words (excluding abstract and references), no sections or subheadings.
Abstract – A short two sentence summary, maximum 50 words.
References – A maximum of 10.
Figures/Tables – A maximum of 1.
Supplementary data
(Supplementary Table 1)
(Supplementary Figures 1 and 2)
Submissions containing images of electrophoretic blots, gels, and microscopy must provide original, uncropped and unadjusted images as additional files for review. Please consider the provided examples before submitting your manuscript.
Below is an example of a vertically cropped western blot. It was cropped around the band of the predicted size of a protein of interest:
Below is an example of a vertically and horizontally cropped western blot. It was cropped around the band of the predicted size of a protein of interest and to only include a control and treatment group of interest:
Below is the uncropped blot. You can see the shadow of the ladder on the left, the edges of the membrane and non-specific bands. Highlight in red are the regions show in the cropped image. Depending on the experimental context, the authors may need to explain the other bands or specificity of the antibody. If a membrane is cut to probe different proteins of different sizes, this should be indicated in the supplemental data legend.
Editorial policies
Manuscript transfer to Reproduction and Fertility
Human and animal studies
- Give the full binomial Latin names for all experimental animals other than common laboratory animals
- State the breed or strain and source of animals, and give details of age, weight, sex and housing
- Detail the procedures and anaesthetics used, including doses given
Gene and protein nomenclature
- In gene and protein symbols, substitute Greek letters with the corresponding roman letter, e.g. TGFBR2 not TGFβR2
- Avoid hyphens unless they are part of the approved symbol, e.g. IGF1 not IGF-1
- Please use arabic rather than roman numerals, e.g. BMPR2 not BMPRII
Mice and rats
- Gene symbols should be in italics with only the first letter capitalised, eg Sox2
- Protein designations should be the same as the gene symbols except that all letters should be capitalised and in roman (ie not italicised), eg SOX2
- Please use symbols approved by the International Committee on Standardized Genetic Nomenclature for Mice and the Rat Genome and Nomenclature Committee, which can be queried at the MGI website
Humans, non-human primates and domestic species
- Gene symbols should be in italics with all letters capitalised, eg SOX2
- Protein designations should be the same as the gene symbols but not italicised, eg SOX2
- Please use symbols approved by the HUGO Gene Nomenclature Committee (HGNC)
Fish
- Gene symbols should be in italics with all letters in lower case, eg sox2
- Protein designations should be the same as the gene symbols but not italicised and with the first letter capitalised, eg Sox2
- Please use symbols approved by the Zebrafish Nomenclature Committee (ZNC), which can be queried at the ZFIN website
Digital image integrity
Preprint repositories
Depositing data in public databases
Licence and Copyright
- Subscription. The copyright holder will transfer copyright to the Society for Reproduction and Fertility and grant Bioscientifica an exclusive licence to publish the article.
- Open Access. The copyright holder will grant the Society for Reproduction and Fertility and Bioscientifica a non-exclusive licence to publish the article. For open access, the copyright is retained by the original copyright holder and is not assigned to Society for Reproduction and Fertility or Bioscientifica.
Authors may download a copy of this agreement in advance.
Cover art competition
SRF–Reproduction prize
Eligibility
- All research papers published in the journal are automatically eligible
- For the prize awarded at Fertility 2020 papers must be published between July 2018 and June 2019
Assessment
- Associate Editors will nominate papers for further consideration by the Assessment Panel
- They are asked to nominate papers with high novelty, high impact, an excellent contribution to the field and high quality data
- The Assessment Panel will discuss all of the nominations and decide on a winner based upon the above criteria. The Assessment Panel will comprise of four Associate Editors. They will recommend a decision for verification by the Co-Editors-in-Chief
Prize
- The award will be made to the whole author group and each author will receive a certificate
- One author, preferably the first author, is invited to attend Fertility, with travel, registration and 3 nights' accommodation covered by SRF
- The author will present their work in a dedicated award session in the Fertility programme
- If the authors are not current members of SRF they will be given 1 year's membership
Conditions
- The decision of the assessment panel is final and not subject to appeal
- One award is available per year
Appeals
Authors are entitled to appeal against a rejection decision made by a journal. Appeals should be submitted to the journal email address. We must receive your valid appeal within four weeks of the original decision, otherwise it will not be considered. An appeal is considered to be an extension of the peer review process and so you should not submit your article to another publication whilst an appeal is ongoing.
To be considered, appeals must directly address the reason(s) given for the initial rejection decision. If reviewer reports were included with the decision letter, then these criticisms must be responded to in the appeal, however you should not prepare and submit a revised version of your article with the appeal. Appeals that are received late, do not address reviewers’ criticisms, are dismissive of the reviewer comments, or contain offensive language will not be considered.
Valid appeals will be sent to a member of the journal’s Editorial Board for consideration. Where possible, an independent member of the Editorial Board who was not connected to the original decision will oversee the appeal.
If successful, an appeal may result in the decision being rescinded and a continuation of the peer-review process. If the appeal is rejected, then the original rejection decision is upheld and no further consideration of that article is possible.